1. Home
  2. IMRX vs SRG Comparison

IMRX vs SRG Comparison

Compare IMRX & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • SRG
  • Stock Information
  • Founded
  • IMRX 2008
  • SRG 2014
  • Country
  • IMRX United States
  • SRG United States
  • Employees
  • IMRX N/A
  • SRG N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • SRG Real Estate Investment Trusts
  • Sector
  • IMRX Health Care
  • SRG Real Estate
  • Exchange
  • IMRX Nasdaq
  • SRG Nasdaq
  • Market Cap
  • IMRX 232.9M
  • SRG 236.0M
  • IPO Year
  • IMRX 2021
  • SRG 2015
  • Fundamental
  • Price
  • IMRX $6.87
  • SRG $4.06
  • Analyst Decision
  • IMRX Strong Buy
  • SRG
  • Analyst Count
  • IMRX 5
  • SRG 0
  • Target Price
  • IMRX $17.20
  • SRG N/A
  • AVG Volume (30 Days)
  • IMRX 1.4M
  • SRG 108.2K
  • Earning Date
  • IMRX 11-10-2025
  • SRG 11-14-2025
  • Dividend Yield
  • IMRX N/A
  • SRG N/A
  • EPS Growth
  • IMRX N/A
  • SRG N/A
  • EPS
  • IMRX N/A
  • SRG N/A
  • Revenue
  • IMRX N/A
  • SRG $15,346,000.00
  • Revenue This Year
  • IMRX N/A
  • SRG N/A
  • Revenue Next Year
  • IMRX N/A
  • SRG N/A
  • P/E Ratio
  • IMRX N/A
  • SRG N/A
  • Revenue Growth
  • IMRX N/A
  • SRG N/A
  • 52 Week Low
  • IMRX $1.10
  • SRG $2.43
  • 52 Week High
  • IMRX $10.08
  • SRG $4.72
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 57.97
  • SRG 48.21
  • Support Level
  • IMRX $6.10
  • SRG $3.99
  • Resistance Level
  • IMRX $5.92
  • SRG $4.38
  • Average True Range (ATR)
  • IMRX 0.48
  • SRG 0.16
  • MACD
  • IMRX 0.09
  • SRG -0.02
  • Stochastic Oscillator
  • IMRX 90.11
  • SRG 25.58

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About SRG Seritage Growth Properties

Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.

Share on Social Networks: